Patient characteristics | Low SCS N=113 | Intermediate SCS N=70 | High SCS N=64 | p value | |||
---|---|---|---|---|---|---|---|
Age >65 years | 62 | 54.9% | 26 | 37.1% | 16 | 25.0 | <0.001 |
Age adjusted Charlson Co-morbidity Index ≥3 | 51 | 45.1% | 21 | 30.0% | 18 | 28.1 | 0.033 |
Neoadjuvant chemotherapy | 103 | 91.2% | 44 | 62.9% | 25 | 39.1% | <0.001 |
Peritoneal Carcinomatosis Index ≤6 | 65 | 57.5% | 18 | 25.7% | 2 | 3.1% | <0.001 |
7 to 12 | 21 | 18.6% | 29 | 41.4% | 6 | 9.4% | |
>12 | 27 | 23.9% | 23 | 32.9% | 56 | 87.5% | |
No visible residual disease | 63 | 55.8% | 50 | 71.4% | 40 | 62.5% | 0.007 |
<1 cm residual disease | 29 | 25.7% | 17 | 24.3% | 21 | 32.8% | |
≥1 cm residual disease | 21 | 18.6% | 3 | 4.3% | 3 | 4.7% |